Ted Driscoll
Chairman at NuMedii, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Nat Goldhaber | M | - |
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | 19 years |
Tami Flores | F | - |
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | 19 years |
Gini Deshpande | M | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 years |
Randy Hawks | M | 73 |
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | 19 years |
Paul Straub | M | - |
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | 19 years |
Atul J. Butte | M | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 years |
Samuel Saks | M | 69 |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 11 years |
Brad C. Webb | M | - |
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | 19 years |
Athena Countouriotis | M | 52 |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 6 years |
Linda Ara | F | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | - |
Craig Webb | M | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Edward C. Driscoll | M | 71 |
Focus Surgery, Inc.
Focus Surgery, Inc. Medical SpecialtiesHealth Technology Part of Sonablate Corp., Focus Surgery, Inc. develops products using High Intensity Focused Ultrasound (HIFU) for the treatment of cancer and soft tissue diseases. The company is based in Indianapolis, IN. The company was founded by Narendra T. Sanghvi. Focus Surgery was acquired by Sonablate Corp. on July 02, 2008. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ted Driscoll
- Personal Network